Prostate Cancer - Results from #24880

Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: A systematic review - Abstract November 1, 2012

Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score - Abstract November 1, 2012

BJUI Mini Reviews - Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel October 31, 2012

Peg-filgrastim and cabazitaxel in prostate cancer patients - Abstract October 31, 2012

TMPRSS2-ERG fusion transcripts in matched urine and needle rinse material after biopsy for the detection of prostate cancer - Abstract October 31, 2012

Who benefits from a psychosocial counselling versus educational intervention to improve psychological quality of life in prostate cancer survivors? - Abstract October 31, 2012

Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma - Abstract October 31, 2012

Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): Lack of utility to stratify cancer risks associated with HGPIN - Abstract October 31, 2012

The national burden of infections after prostate biopsy in England and Wales: A wake-up call for better prevention - Abstract October 31, 2012

Management of bone metastases in refractory prostate cancer - role of denosumab - Abstract October 31, 2012

Prostate cancer screening practices of African-American and non-African-American US primary care physicians: A cross-sectional survey - Abstract October 31, 2012

Statin use and risk of prostate cancer: A meta-analysis of observational studies - Abstract October 31, 2012

Prostate segmentation by sparse representation based classification - Abstract October 30, 2012

A model of the cost-effectiveness of intensity-modulated radiotherapy in comparison with three-dimensional conformal radiotherapy for the treatment of localised prostate cancer - Abstract October 30, 2012

A phase 3, double-blind, randomised, parallel-group, placebo-controlled study of oral weekly alendronate for the prevention of androgen deprivation bone loss in nonmetastatic prostate cancer: The Cancer and Osteoporosis Research with Alendronate and Leupr October 30, 2012

Treatment-related morbidity in prostate cancer: A comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers - Abstract October 30, 2012

Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer - Abstract October 30, 2012

Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy - Abstract October 30, 2012

New perspectives in the therapy of castration resistant prostate cancer - Abstract October 30, 2012

Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: Trends over time in a European randomized trial - Abstract October 30, 2012

Page 1245 of 1455